1. Home
  2. PRPO

as of 01-02-2026 3:32pm EST

$23.38
+$0.40
+1.74%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Founded: N/A Country:
United States
United States
Employees: N/A City: OMAHA
Market Cap: 32.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 7.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.82 EPS Growth: N/A
52 Week Low/High: $3.90 - $28.50 Next Earning Date: 11-14-2025
Revenue: $22,800,000 Revenue Growth: 30.95%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered PRPO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 67.11%
67.11%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: